
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1032 | 949 | 1032 | 1061 | 1383 | 2454 |
Fund Return | 3.24% | -5.07% | 3.24% | 1.99% | 6.7% | 9.39% |
Place in category | 336 | 604 | 336 | 124 | 103 | 69 |
% in Category | 34 | 62 | 34 | 21 | 21 | 23 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Legal General US Index Trust F Dist | 21.83K | 4.48 | 15.24 | 15.21 | ||
Legal General US Index Trust C Acc | 3.37B | 4.50 | 15.58 | 15.55 | ||
Legal General US Index Trust C Dist | 786.61M | 4.51 | 15.59 | 15.55 | ||
Legal General US Index Trust F Acc | 516.87K | 4.46 | 15.26 | 15.22 | ||
Legal General US Index Trust I Acc | 1.55B | 27.16 | 11.15 | 15.07 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund U G | 3.89B | 6.94 | 10.61 | 10.46 | ||
Wellington Global Health Care EquiG | 1.92B | 6.70 | 4.03 | 11.14 | ||
Adamant Medtech I GBP | 1.48B | 10.05 | 7.78 | 12.87 | ||
Global Health Care Fund W Acc GBP | 101.95M | 7.87 | 5.51 | 9.11 | ||
Pharmaceuticals Index Trust F Acc | 256.43K | 7.73 | 7.29 | 9.38 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.67 | 813.48 | +1.48% | |
UnitedHealth | US91324P1021 | 6.67 | 488.65 | +1.48% | |
J&J | US4781601046 | 4.97 | 162.81 | -0.11% | |
AbbVie | US00287Y1091 | 4.65 | 211.77 | +0.10% | |
Novo Nordisk B | DK0062498333 | 4.42 | 544.5 | +2.70% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | Neutral |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review